Policy | August 03, 2021
API exports surpass imports by value in 2020-21
The govt has rolled out three schemes for promoting the manufacture of API
The govt has rolled out three schemes for promoting the manufacture of API
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
The first six batches are being shipped to the Gamaleya Center, Moscow for the quality approval
The Cephalosporin Injectables plant has a total capacity of 26.4 million vials per year while Ethiopia is having a demand for 16 million vials
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
The first batch will be shipped to the Gamaleya Center for the quality control
2DG has been given emergency approval by the Drug Controller General of India (DCGI) for use on COVID-19 patients in the country
The company has reported total income of Rs.45.29 crores during the 12 months period ended March 31, 2021
Ranitidine Hydrochloride is an important product for Solara and is manufactured at its Cuddalore site
2DG has been given emergency approval by the Drug Controller General of India for COVID-19 patients in the country
Subscribe To Our Newsletter & Stay Updated
